Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 1.052
2.
Clin Nucl Med ; 49(4): 335-337, 2024 Apr 01.
Article En | MEDLINE | ID: mdl-38377379

ABSTRACT: A 51-year-old man with newly diagnosed small cell neuroendocrine carcinoma of the prostate was referred for a staging 18 F-DCFPyL PET/CT, which showed a solitary metastasis in the left acetabulum. Subsequent 18 F-FDG PET/CT showed intense uptake throughout the prostate as well as extensive avid pelvic and thoracic nodal disease and redemonstration of the left acetabular metastasis. Despite initial metabolic response to treatment, subsequent 18 F-FDG PET 8 months later revealed significant progression of nodal disease above and below the diaphragm, as well as multiple new sites of metastases.


Carcinoma, Neuroendocrine , Carcinoma, Small Cell , Male , Humans , Middle Aged , Fluorodeoxyglucose F18 , Positron Emission Tomography Computed Tomography , Prostate , Positron-Emission Tomography , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Neuroendocrine/diagnostic imaging
4.
Clin Nucl Med ; 48(11): 1003-1005, 2023 Nov 01.
Article En | MEDLINE | ID: mdl-37796160

ABSTRACT: Primary small cell neuroendocrine carcinomas are extremely rare heterogeneous neoplasms. We present 68 Ga-FAPI (fibroblast activation protein inhibitor) PET/CT findings of small cell neuroendocrine carcinoma of the gallbladder in a 57-year-old woman. This rare gallbladder small cell neuroendocrine carcinoma demonstrated intense tracer uptake on 68 Ga-FAPI PET/CT. This demonstrates the potential value of 68 Ga-FAPI PET/CT for evaluation of gallbladder small cell neuroendocrine carcinoma.


Carcinoma, Neuroendocrine , Carcinoma, Small Cell , Gallbladder Neoplasms , Female , Humans , Middle Aged , Positron Emission Tomography Computed Tomography , Gallbladder Neoplasms/diagnostic imaging , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Neuroendocrine/diagnostic imaging , Fluorodeoxyglucose F18
6.
J Int Med Res ; 51(6): 3000605231182883, 2023 Jun.
Article En | MEDLINE | ID: mdl-37365923

Small cell cancer (SCC) of the gallbladder is a rare and highly aggressive malignancy. We report here a case diagnosed by positron emission tomography/computed tomography (PET-CT) combined with tumour markers. A 51-year-old man presented with pain in his neck, shoulder, back, lumbar and right thigh. Ultrasonography showed an isoechoic mass in the gallbladder, and a magnetic resonance image (MRI) scan showed multiple retroperitoneal occupations and multiple vertebral bone destruction with pathological fractures. Blood analysis showed elevated levels of tumour markers including neuron-specific enolase (NSE) and PET/CT images showed extensive distant metastases. A diagnosis of primary SCC of the gallbladder was made following exclusion of the possibility of metastasis from other organs. The use of biomarkers with immunohistochemical findings and PET/CT imaging, will assist clinicians in the identification and understanding of the pathology of this disease.


Carcinoma, Small Cell , Positron Emission Tomography Computed Tomography , Male , Humans , Middle Aged , Positron Emission Tomography Computed Tomography/methods , Fluorodeoxyglucose F18 , Radiopharmaceuticals , Positron-Emission Tomography/methods , Carcinoma, Small Cell/diagnostic imaging , Gallbladder , Biomarkers, Tumor , Magnetic Resonance Imaging/methods
7.
Clin Nucl Med ; 48(7): e340-e342, 2023 Jul 01.
Article En | MEDLINE | ID: mdl-37167139

ABSTRACT: Primary small cell neuroendocrine carcinoma of endometrium is very rare and aggressive carcinoma. Most patients present with metastases at the time of diagnosis and have very poor prognosis. Only very few cases are reported in literature. Here we present a case of 67-year-old woman, who on evaluation for mild pain abdomen was subsequently diagnosed to have metastatic small cell neuroendocrine carcinoma of endometrium on PET/CT scan and biopsy.


Carcinoma, Neuroendocrine , Carcinoma, Small Cell , Endometrial Neoplasms , Female , Humans , Aged , Positron Emission Tomography Computed Tomography , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnostic imaging , Endometrium , Prognosis , Endometrial Neoplasms/diagnostic imaging , Endometrial Neoplasms/pathology , Carcinoma, Neuroendocrine/diagnostic imaging , Carcinoma, Neuroendocrine/pathology
8.
Indian J Pathol Microbiol ; 66(1): 155-158, 2023.
Article En | MEDLINE | ID: mdl-36656229

Neuroendocrine neoplasms are derived from the epithelial lineages mainly of respiratory tract, with predominant neuroendocrine differentiation. There are only a handful of documented cases of paranasal small cell neuroendocrine carcinomas (SNEC) with primary orbital involvement. Here, the authors describe a 33-year-old male patient with rapidly progressive swelling of the right lower lid with proptosis since 4 weeks. On contrast-MRI orbit, an ill-defined multilobulated mass measuring 3.6 × 3.1 cm with intense homogenous enhancement was seen in the right retrobulbar space involving the right ethmoid sinus. On incisional biopsy, a poorly differentiated mass containing numerous small round blue cells and scanty intervening stroma with prominent necrosis and apoptosis was seen. Immunohistochemistry was strongly positive for synaptophysin. He was diagnosed as a case of SNEC and received chemotherapy, with good response till date of 9 months of follow up. The authors present a literature review and describe challenges in management of a primary orbital SNEC.


Carcinoma, Neuroendocrine , Carcinoma, Small Cell , Neuroendocrine Tumors , Orbital Neoplasms , Paranasal Sinus Neoplasms , Male , Humans , Adult , Carcinoma, Neuroendocrine/diagnostic imaging , Carcinoma, Neuroendocrine/drug therapy , Paranasal Sinus Neoplasms/diagnosis , Paranasal Sinus Neoplasms/pathology , Orbital Neoplasms/diagnostic imaging , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Small Cell/pathology
10.
Article En | MEDLINE | ID: mdl-35894814

Thymic neuroendocrine tumours are rare anterior mediastinal neoplasms often associated with paraneoplastic syndromes. A patient presented with intractable hyponatraemia and a DOTATATE-avid mediastinal mass. Following medical optimization, she underwent thoracoscopic thymectomy with en bloc thymic small-cell carcinoma resection. Her symptoms resolved and her sodium levels normalized. In localized disease, curative-intent, minimally invasive thymic neuroendocrine tumour resection is safe and effective following preoperative staging and paraneoplastic syndrome management.


Carcinoma, Small Cell , Paraneoplastic Syndromes , Thymus Neoplasms , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Small Cell/surgery , Female , Humans , Paraneoplastic Syndromes/etiology , Paraneoplastic Syndromes/surgery , Positron-Emission Tomography , Radionuclide Imaging , Thymoma , Thymus Neoplasms/complications , Thymus Neoplasms/diagnostic imaging , Thymus Neoplasms/surgery , Vasopressins
11.
Clin Nucl Med ; 47(3): 255-257, 2022 Mar 01.
Article En | MEDLINE | ID: mdl-34392287

ABSTRACT: A 65-year-old man with fluciclovine-avid metastatic prostate small cell carcinoma with prostate-specific antigen (PSA) 19.4 ng/mL at diagnosis underwent system therapy and subsequent surgery and achieved hormonal response with PSA <0.1 ng/mL. An 18F-fluciclovine PET/CT scan 3 months after surgery was negative for disease. Although PSA remained <0.1 ng/mL, the rising carcinoembryonic antigen prompted an 18F-FDG PET/CT 6 weeks later. It showed multiple hypermetabolic lesions in the prostatectomy bed, liver, and right iliac bone, suggestive of malignant disease. The FDG-avid prostatectomy lesions were further confirmed on MRI. This case demonstrates that FDG PET/CT has a role in suspected metastatic prostate small cell carcinoma with negative fluciclovine PET examination.


Carcinoma, Small Cell , Prostatic Neoplasms , Aged , Carcinoma, Small Cell/diagnostic imaging , Fluorodeoxyglucose F18 , Humans , Male , Neoplasm Metastasis , Positron Emission Tomography Computed Tomography , Prostate , Prostate-Specific Antigen , Prostatic Neoplasms/diagnostic imaging
12.
Am J Case Rep ; 22: e932274, 2021 Sep 27.
Article En | MEDLINE | ID: mdl-34570746

BACKGROUND Primary breast small cell neuroendocrine carcinoma is a rare subtype of breast cancer with about 57 cases reported in the literature. This rare type of cancer represents about 0.1% of breast carcinomas. Recently, the World Health Organization defined this type of cancer as a separate entity from other breast cancer types. The diagnosis of this type of cancer in the breast is difficult because the histological pattern is similar to the small cell neuroendocrine carcinoma of other more common primary sites of origin, including the lung. CASE REPORT A 39-year-old woman presented to our hospital with a left breast mass and recurrent mastitis. Physical examination revealed a painless lump in her left breast with a brown-colored discharge from the nipple, and her child refused breastfeeding from the left breast. A high-density well-defined rounded mass was observed upon mammography in the upper lateral aspect of the left breast. This mass lesion appeared hypoechoic with no posterior acoustic shadowing on ultrasound scan. A core-needle biopsy of the mass was performed and the diagnosis of small cell neuroendocrine carcinoma was rendered after histopathologic examination. Positron emission tomography scanning was helpful in the exclusion of primary origin from other organ sites; thus, the primary breast origin of the tumor was confirmed. CONCLUSIONS This case report provides a comprehensive approach to diagnose this type of small cell carcinoma originating primarily in the breast. The suspicion of this type of breast cancer should be raised if there is presence of characteristic histopathologic findings with the exclusion of any primary origin from other organ sites by the help of imaging studies.


Breast Neoplasms , Carcinoma, Neuroendocrine , Carcinoma, Small Cell , Adult , Breast/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Carcinoma, Neuroendocrine/diagnostic imaging , Carcinoma, Small Cell/diagnostic imaging , Female , Humans , Mammography
14.
Transl Res ; 233: 77-91, 2021 07.
Article En | MEDLINE | ID: mdl-33618009

Lung cancer screening detects early-stage cancers, but also a large number of benign nodules. Molecular markers can help in the lung cancer screening process by refining inclusion criteria or guiding the management of indeterminate pulmonary nodules. In this study, we developed a diagnostic model based on the quantification in plasma of complement-derived fragment C4c, cytokeratin fragment 21-1 (CYFRA 21-1) and C-reactive protein (CRP). The model was first validated in two independent cohorts, and showed a good diagnostic performance across a range of lung tumor types, emphasizing its high specificity and positive predictive value. We next tested its utility in two clinically relevant contexts: assessment of lung cancer risk and nodule malignancy. The scores derived from the model were associated with a significantly higher risk of having lung cancer in asymptomatic individuals enrolled in a computed tomography (CT)-screening program (OR = 1.89; 95% CI = 1.20-2.97). Our model also served to discriminate between benign and malignant pulmonary nodules (AUC: 0.86; 95% CI = 0.80-0.92) with very good specificity (92%). Moreover, the model performed better in combination with clinical factors, and may be used to reclassify patients with intermediate-risk indeterminate pulmonary nodules into patients who require a more aggressive work-up. In conclusion, we propose a new diagnostic biomarker panel that may dictate which incidental or screening-detected pulmonary nodules require a more active work-up.


Antigens, Neoplasm/blood , C-Reactive Protein/analysis , Early Detection of Cancer/methods , Keratin-19/blood , Lung Neoplasms/blood , Lung Neoplasms/diagnosis , Peptide Fragments/blood , Biomarkers, Tumor/blood , Carcinoma, Non-Small-Cell Lung/blood , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Carcinoma, Small Cell/blood , Carcinoma, Small Cell/diagnosis , Carcinoma, Small Cell/diagnostic imaging , Cohort Studies , Complement C4b , Early Detection of Cancer/statistics & numerical data , Female , Humans , Lung Neoplasms/diagnostic imaging , Male , Models, Biological , Molecular Diagnostic Techniques/methods , Molecular Diagnostic Techniques/statistics & numerical data , Sensitivity and Specificity , Solitary Pulmonary Nodule/blood , Solitary Pulmonary Nodule/diagnosis , Solitary Pulmonary Nodule/diagnostic imaging , Tomography, X-Ray Computed , Translational Research, Biomedical
15.
World Neurosurg ; 148: 70-79, 2021 04.
Article En | MEDLINE | ID: mdl-33418120

BACKGROUND: A combined transcranial and transfacial approach has long been the gold standard for surgical management of large tumors with sinonasal and skull base involvement. The extended endoscopic endonasal approach for such pathologies has its advantages, but it has flaws as well, such as anatomic limitations and more ponderous skull base reconstruction and thus higher risk of postoperative complications. Our primary technique for surgical treatment of these pathologies has been a combination of transfacial and minimally invasive transciliary supraorbital keyhole approaches. With the aim to further minimize invasiveness, potential complications, and unsatisfactory aesthetic outcomes during surgical treatment of large tumors invading both the sinonasal area and the skull base, we abandoned the transfacial approach and simultaneously combined the transciliary supraorbital keyhole approach with the endoscopic endonasal approach. METHODS: The well-known microscope-assisted minimally invasive approach via a transciliary supraorbital keyhole craniotomy was combined with the endoscopic endonasal approach. RESULTS: Six patients with different histologic types of tumors affecting the sinonasal area and the skull base were operated on. The mean operative time was 3 hours, there were no unexpected intraoperative or postoperative complications, and total tumor removal was achieved in each patient. None of the patients experienced complications associated with the surgery during follow-up. CONCLUSIONS: Our combined simultaneous multiportal approach enables total tumor eradication with reduced operative time and is associated with minimal intraoperative and postoperative complications, low mortality rate, and excellent cosmetic results.


Carcinoma, Small Cell/surgery , Carcinoma, Verrucous/surgery , Esthesioneuroblastoma, Olfactory/surgery , Meningioma/surgery , Microsurgery/methods , Neuroendoscopy/methods , Paranasal Sinus Neoplasms/surgery , Skull Base Neoplasms/surgery , Adult , Carcinoma/diagnostic imaging , Carcinoma/surgery , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Verrucous/diagnostic imaging , Esthesioneuroblastoma, Olfactory/diagnostic imaging , Ethmoid Sinus/diagnostic imaging , Ethmoid Sinus/surgery , Female , Humans , Length of Stay , Male , Maxillary Sinus Neoplasms/diagnostic imaging , Maxillary Sinus Neoplasms/surgery , Meningeal Neoplasms/diagnostic imaging , Meningeal Neoplasms/surgery , Meningioma/diagnostic imaging , Middle Aged , Nasal Cavity , Nose Neoplasms/diagnostic imaging , Nose Neoplasms/surgery , Paranasal Sinus Neoplasms/diagnostic imaging , Skull Base Neoplasms/diagnostic imaging , Young Adult
16.
World Neurosurg ; 145: 278-281, 2021 01.
Article En | MEDLINE | ID: mdl-33010512

BACKGROUND: Although carcinoma metastasis to primary intracranial neoplasms has occasionally been reported, metastasis to a cerebral arteriovenous malformation (AVM) has been exceedingly rare, with only 5 cases reported to date. In the present study, we have reported a case of lung carcinoma that had metastasized to a cerebral AVM. To the best of our knowledge, the present report is the first case in which the pathological examination detected the bleeding mechanism of this rare condition, showing destruction of the feeders by the metastatic tumor. CASE DESCRIPTION: A 61-year-old man who had had a tumor shadow in the right middle lung field identified at a medical examination 5 weeks previously had suddenly experienced a disturbance of consciousness. Head computed tomography and computed tomography angiography revealed a right occipital subcortical hemorrhage with abnormal vessels, suggesting a ruptured AVM. Magnetic resonance imaging with gadolinium-based contrast agents did not show any other lesions. Cerebral angiography revealed a Spetzler-Martin grade III AVM in the right occipital lobe. Endovascular feeder embolization and subsequent removal of the AVM were performed. Histopathological examination of the resected mass showed a small cell carcinoma that had metastasized to the AVM. The tumor cells had infiltrated to the vessel walls of the feeders, which might have elicited the bleeding. CONCLUSION: Although rare, clinicians should recognize that undifferentiated carcinomas can metastasize to AVMs and cause bleeding. Because the preoperative diagnosis can be difficult, even using the latest imaging modalities, careful examination of the resected specimen is required to reveal such pathological conditions.


Brain Neoplasms/secondary , Carcinoma, Small Cell/secondary , Intracranial Arteriovenous Malformations/pathology , Lung Neoplasms/pathology , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Small Cell/pathology , Cerebral Angiography , Computed Tomography Angiography , Drainage , Embolization, Therapeutic , Fatal Outcome , Humans , Intracranial Arteriovenous Malformations/diagnostic imaging , Intracranial Arteriovenous Malformations/surgery , Intracranial Hemorrhages/diagnostic imaging , Intracranial Hemorrhages/etiology , Magnetic Resonance Imaging , Male , Middle Aged , Tomography, X-Ray Computed
19.
Rheumatol Int ; 41(2): 493-499, 2021 Feb.
Article En | MEDLINE | ID: mdl-32671469

Granulomatosis with polyangiitis (GPA) is a potentially lethal ANCA-associated small-vessel vasculitis characterized by a typical triad of upper respiratory tract, lung, and kidney involvement. Lung involvement in GPA occurs in 25-80% of cases. The most common radiographic and computed tomography (CT) abnormalities of pulmonary GPA are lung nodules and masses, very often multiple and with cavitation. As there are various clinical presentations, the diagnosis of GPA can be challenging, and the illness is difficult to distinguish from other diseases such as infection or malignancy. Following the improved survival rates in patients with GPA, there is accumulating evidence to suggest an increased occurrence of different types of cancer. Exposure to cyclophosphamide seems to be one of its main causes. We present the case of a patient with chronic GPA who was hospitalized owing to a new infiltrate in the lung, suggesting relapse of the disease, and finally diagnosed with small cell lung cancer. Data regarding lung cancer in GPA patients are limited. While there are some case reports and short case series in the literature, there are no detailed data regarding an association between CYC exposure and lung cancer development in vasculitis. It is necessary to consider the causes of pulmonary masses other than a GPA relapse. Bronchoscopy with biopsy and histopathological examination are crucial in proper differential diagnosis. GPA patients require long-term follow-up to monitor for the development of complications during treatment.


Carcinoma, Small Cell/pathology , Granulomatosis with Polyangiitis/diagnosis , Lung Neoplasms/pathology , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnostic imaging , Causality , Cyclophosphamide/administration & dosage , Diagnosis, Differential , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/drug therapy , Humans , Immunosuppressive Agents/administration & dosage , Lung Neoplasms/complications , Lung Neoplasms/diagnostic imaging , Male , Middle Aged
20.
J Comput Assist Tomogr ; 45(1): 135-141, 2021.
Article En | MEDLINE | ID: mdl-32649429

PURPOSE: The purpose of this study was to explore the characteristic computed tomography (CT) and magnetic resonance (MR) features of small cell neuroendocrine carcinoma (SNEC) of paranasal sinuses. MATERIALS AND METHODS: Computed tomography (n = 8) and MR (n = 14) images and clinical findings from 14 patients with SNEC of paranasal sinuses were retrospectively reviewed. RESULTS: Eight lesions were located in the ethmoidal sinus, 4 in the maxillary sinus, and 2 in the sphenoid sinus. Small cell neuroendocrine carcinoma of the sphenoid sinus showed bilateral asymmetry patterns. On CT images, bony changes were visible in all 8 cases. On MR, 4 cases contained hemorrhage, and 10 cases contained cystic or necrotic areas. All cases demonstrated marked heterogeneous enhancement, with half showing a "cribriform-like" or "geographic" appearance. The nasal cavity was the most common site invaded by SNEC of paranasal sinuses, followed by the orbits. A time-signal intensity curve examination showed a washout-type pattern in all but 1 case. The mean ± SD apparent diffusion coefficient value was 0.702 ± 0.112 (×10-3 mm2/s). According to the Dulguerov staging system, 9 tumors were staged as N0 (1 T1, 1 T2, 5 T3, and 2 T4). The recurrence rate was 64.3%. CONCLUSIONS: Some characteristics of radiological findings can provide important clues for preoperative diagnosis.


Carcinoma, Neuroendocrine/diagnostic imaging , Carcinoma, Small Cell/diagnostic imaging , Ethmoid Sinus/pathology , Paranasal Sinus Neoplasms/diagnostic imaging , Sphenoid Sinus/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Neuroendocrine/pathology , Carcinoma, Small Cell/pathology , Ethmoid Sinus/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Paranasal Sinus Neoplasms/pathology , Preoperative Period , Retrospective Studies , Sensitivity and Specificity , Sphenoid Sinus/diagnostic imaging , Tomography, X-Ray Computed
...